Serum and glucocorticoid-inducible kinase 1 (SGK1) is necessary for vascular remodeling during angiogenesis

Developmental Dynamics

Volumn 239, Issue 8, 2010, Pages 2149-2160

  Catela, Catarina ^a,c   Kratsios, Paschalis ^a   Hede, Marianne ^a   Lang, Florian ^b   Rosenthal, Nadia ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Arterial specification; Notch signaling; SGK1

Indexed keywords

BIOLOGICAL MARKER; NOTCH RECEPTOR; SERUM AND GLUCOCORTICOID REGULATED KINASE 1;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE EXPRESSION; GENETICS; LETHALITY; MALE; MOUSE; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL;

ANIMALS; BLOOD VESSELS; CARDIOVASCULAR SYSTEM; CELL SURVIVAL; ENDOTHELIAL CELLS; IMMEDIATE-EARLY PROTEINS; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN-SERINE-THREONINE KINASES;

MAMMALIA;

EID: 77955000556     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.22345     Document Type: Article

References (58)

1. Adams RH. 2003. Molecular control of arterial-venous blood vessel identity. J Anat 202:105-112.
2. Amato R, D'Antona L, Porciatti G, Agosti V, Menniti M, Rinaldo C, Costa N, Bellacchio E, Mattarocci S, Fuiano G, Soddu S, Paggi MG, Lang F, Perrotti N. 2009. Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation. J Mol Med 87:1221-1239.
3. Aoyama T, Matsui T, Novikov M, Park J, Hemmings B, Rosenzweig A. 2005. Serum and glucocorticoid-responsive kinase-1 regulates cardiomyocyte survival and hypertrophic response. Circulation 111:1652-1659.
4. Argraves WS, Drake CJ. 2005. Genes critical to vasculogenesis as defined by systematic analysis of vascular defects in knockout mice. Anat Rec A Discov Mol Cell Evol Biol 286:875-884.
5. Biondi RM, Kieloch A, Currie RA, Deak M, Alessi DR. 2001. The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB. EMBO J 20:4380-4390.
6. Boulday G, Fitau J, Coupel S, Soulillou JP, Charreau B. 2004. Exogenous tissue inhibitor of metalloproteinase-1 promotes endothelial cell survival through activation of the phosphatidylinositol 3-kinase/Akt pathway. Ann NY Acad Sci 1030:28-36.
7. Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME. 2001. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 21:952-965. (Pubitemid 32104742)
8. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439.
9. Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, Bono F, Balconi G, Spagnuolo R, Oosthuyse B, Dewerchin M, Zanetti A, Angellilo A, Mattot V, Nuyens D, Lutgens E, Clotman F, de Ruiter MC, Gittenberger-de Groot A, Poelmann R, Lupu F, Herbert JM, Collen D, Dejana E. 1999. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98:147-157.
10. Conlon RA, Reaume AG, Rossant J. 1995. Notch1 is required for the coordinate segmentation of somites. Development 121:1533-1545.
11. Coultas L, Chawengsaksophak K, Rossant J. 2005. Endothelial cells and VEGF in vascular development. Nature 438:937-945.
12. De Val S, Black BL. 2009. Transcriptional control of endothelial cell development. Dev Cell 16:180-195.
13. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ. 1995. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121:1845-1854.
14. Duronio V. 2008. The life of a cell: apoptosis regulation by the PI3K/PKB pathway. Biochem J 415:333-344.
15. Ferguson JE, 3rd, Kelley RW, Patterson C. 2005. Mechanisms of endothelial differentiation in embryonic vasculogenesis. Arterioscler Thromb Vasc Biol 25:2246-2254.
16. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'shea KS, Powell-Braxton L, Hillan KJ, Moore MW. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442.
17. Firestone GL, Giampaolo JR, O'Keeffe BA. 2003. Stimulus-dependent regulation of serum and glucocorticoid inducible protein kinase (SGK) transcription, subcellular localization and enzymatic activity. Cell Physiol Biochem 13:1-12.
18. Fischer A, Schumacher N, Maier M, Sendtner M, Gessler M. 2004. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev 18:901-911. (Pubitemid 38529659)
19. Gale NW, Dominguez MG, Noguera I, Pan L, Hughes V, Valenzuela DM, Murphy AJ, Adams NC, Lin HC, Holash J, Thurston G, Yancopoulos GD. 2004. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci USA 101:15949-15954.
20. Goldie LC, Nix MK, Hirschi KK. 2008. Embryonic vasculogenesis and hematopoietic specification. Organogenesis 4:257-263.
21. Grahammer F, Artunc F, Sandulache D, Rexhepaj R, Friedrich B, Risler T, McCormick JA, Dawson K, Wang J, Pearce D, Wulff P, Kuhl D, Lang F. 2006. Renal function of gene-targeted mice lacking both SGK1 and SGK3. Am J Physiol Regul Integr Comp Physiol 290:R945-R950.
22. Graupera M, Guillermet-Guibert J, Foukas LC, Phng LK, Cain RJ, Salpekar A, Pearce W, Meek S, Millan J, Cutillas PR, Smith AJ, Ridley AJ, Ruhrberg C, Gerhardt H, Vanhaesebroeck B. 2008. Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration. Nature 453:662-666.
23. Grego-Bessa J, Luna-Zurita L, del Monte G, Bolos V, Melgar P, Arandilla A, Garratt AN, Zang H, Mukouyama YS, Chen H, Shou W, Ballestar E, Esteller M, Rojas A, Perez-Pomares JM, de la Pompa JL. 2007. Notch signaling is essential for ventricular chamber development. Dev Cell 12:415-429.
24. Hertweck M, Gobel C, Baumeister R. 2004. C. elegans SGK-1 is the critical component in the Akt/PKB kinase complex to control stress response and life span. Dev Cell 6:577-588.
25. High FA, Lu MM, Pear WS, Loomes KM, Kaestner KH, Epstein JA. 2008. Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development. Proc Natl Acad Sci USA 105:1955-1959.
26. Kamath BM, Spinner NB, Emerick KM, Chudley AE, Booth C, Piccoli DA, Krantz ID. 2004. Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation 109:1354-1358.
27. Karamysheva AF. 2008. Mechanisms of angiogenesis. Biochemistry (Mosc) 73:751-762.
28. Kobayashi T, Deak M, Morrice N, Cohen P. 1999. Characterization of the structure and regulation of two novel isoforms of serum-and glucocorticoid- induced protein kinase. Biochem J 344(pt 1):189-197.
29. Kokubo H, Miyagawa-Tomita S, Nakazawa M, Saga Y, Johnson RL. 2005. Mouse hesr1 and hesr2 genes are redundantly required to mediate Notch signaling in the developing cardiovascular system. Dev Biol 278:301-309. (Pubitemid 40175030)
30. Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP, Gallahan D, Closson V, Kitajewski J, Callahan R, Smith GH, Stark KL, Gridley T. 2000. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev 14:1343-1352.
31. Krebs LT, Shutter JR, Tanigaki K, Honjo T, Stark KL, Gridley T. 2004. Haploin-sufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev 18:2469-2473.
32. Lang F, Cohen P. 2001. Regulation and physiological roles of serum-and glucocorticoid-induced protein kinase isoforms. Sci STKE 2001:re17.
33. Lang F, Bohmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V. 2006. (Patho) physiological significance of the serumand glucocorticoid-inducible kinase isoforms. Physiol Rev 86:1151-1178.
34. Lawson ND, Scheer N, Pham VN, Kim CH, Chitnis AB, Campos-Ortega JA, Weinstein BM. 2001. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128:3675-3683.
35. Lee E, Lein ES, Firestone GL. 2001. Tissue- specific expression of the transcriptionally regulated serum and glucocorticoid-inducible protein kinase (Sgk) during mouse embryogenesis. Mech Dev 103:177-181.
36. Li L, Miano JM, Cserjesi P, Olson EN. 1996. SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ Res 78:188-195. (Pubitemid 26042837)
37. Li L, Krantz ID, Deng Y, Genin A, Banta AB, Collins CC, Qi M, Trask BJ, Kuo WL, Cochran J, Costa T, Pierpont ME, Rand EB, Piccoli DA, Hood L, Spinner NB. 1997. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 16:243-251.
38. Limbourg FP, Takeshita K, Radtke F, Bronson RT, Chin MT, Liao JK. 2005. Essential role of endothelial Notch1 in angiogenesis. Circulation 111:1826-1832.
39. Liu ZJ, Shirakawa T, Li Y, Soma A, Oka M, Dotto GP, Fairman RM, Velazquez OC, Herlyn M. 2003. Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol 23:14-25.
40. Liu L, Zhu S, Gong Z, Low BC. 2008. Kras/PI3K-Akt signaling is essential for zebrafish hematopoiesis and angiogenesis. PLoS One 3:e2850.
41. Marelli-Berg FM, Peek E, Lidington EA, Stauss HJ, Lechler RI. 2000. Isolation of endothelial cells from murine tissue. J Immunol Methods 244:205-215.
42. McElhinney DB, Krantz ID, Bason L, Piccoli DA, Emerick KM, Spinner NB, Goldmuntz E. 2002. Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation 106:2567-2574.
43. Montagutelli X. 2000. Effect of the genetic background on the phenotype of mouse mutations. J Am Soc Nephrol 11(suppl 16):S101-S105.
44. Oda T, Elkahloun AG, Pike BL, Okajima K, Krantz ID, Genin A, Piccoli DA, Meltzer PS, Spinner NB, Collins FS, Chandrasekharappa SC. 1997. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 16:235-242.
45. Park J, Leong ML, Buse P, Maiyar AC, Firestone GL, Hemmings BA. 1999. Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway. EMBO J 18:3024-3033.
46. Rossant J, Cross JC. 2001. Placental development: lessons from mouse mutants. Nat Rev Genet 2:538-548. (Pubitemid 33674027)
47. Rossant J, Hirashima M. 2003. Vascular development and patterning: making the right choices. Curr Opin Genet Dev 13:408-412.
48. Sedmera D, Pexieder T, Hu N, Clark EB. 1997. Developmental changes in the myocardial architecture of the chick. Anat Rec 248:421-432.
49. Shanmugam I, Cheng G, Terranova PF, Thrasher JB, Thomas CP, Li B. 2007. Serum/glucocorticoid-induced protein kinase-1 facilitates androgen receptor-dependent cell survival. Cell Death Differ 14:2085-2094.
50. Shawber CJ, Kitajewski J. 2004. Notch function in the vasculature: insights from zebrafish, mouse and man. Bioessays 26:225-234.
51. Solway J, Seltzer J, Samaha FF, Kim S, Alger LE, Niu Q, Morrisey EE, Ip HS, Parmacek MS. 1995. Structure and expression of a smooth muscle cell-specific gene, SM22 alpha. J Biol Chem 270:13460-13469.
52. Tessier M, Woodgett JR. 2006. Serum and glucocorticoid-regulated protein kinases: variations on a theme. J Cell Biochem 98:1391-1407.
53. Wang HU, Chen ZF, Anderson DJ. 1998. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93:741-753.
54. Wang J, Barbry P, Maiyar AC, Rozansky DJ, Bhargava A, Leong M, Firestone GL, Pearce D. 2001. SGK integrates insulin and mineralocorticoid regulation of epithelial sodium transport. Am J Physiol Renal Physiol 280:F303-F313.
55. Webster MK, Goya L, Ge Y, Maiyar AC, Firestone GL. 1993. Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol 13:2031-2040. (Pubitemid 23097682)
56. Wulff P, Vallon V, Huang DY, Volkl H, Yu F, Richter K, Jansen M, Schlunz M, Klingel K, Loffing J, Kauselmann G, Bosl MR, Lang F, Kuhl D. 2002. Impaired renal Na(+) retention in the sgk1-knockout mouse. J Clin Invest 110:1263-1268.
57. Xue Y, Gao X, Lindsell CE, Norton CR, Chang B, Hicks C, Gendron-Maguire M, Rand EB, Weinmaster G, Gridley T. 1999. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 8:723-730.
58. Yuan TL, Choi HS, Matsui A, Benes C, Lifshits E, Luo J, Frangioni JV, Cantley LC. 2008. Class 1A PI3K regulates vessel integrity during development and tumorigenesis. Proc Natl Acad Sci USA 105:9739-9744.